Sara Clark, MD
Vascular Surgery · Jacksonville, FLNPI 1972795755
Payments from drug & device makers
Across 215 payments — averaging $63.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Silk Road Medical, Inc.$7K
- Boston Scientific$1K
- Endologix LLC$985
- Medtronic$880
- W. L. Gore & Associates, Inc.$793
- Bolton Medical Inc$660
- plus $2K from 29 others
What the payments were for
- Consulting fees$6004%
- Travel & lodging$6275%
- Food & beverage$12,42891%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Silk Road Medical, Inc. | 78 | $6,956 |
| Boston Scientific | 18 | $1,167 |
| Endologix LLC | 9 | $985 |
| Medtronic(2 entities) | 37 | $880 |
| W. L. Gore & Associates, Inc. | 9 | $793 |
| Bolton Medical Inc | 7 | $660 |
| Shockwave Medical, Inc | 3 | $275 |
| Johnson & Johnson(3 entities) | 12 | $257 |
| Cook Medical LLC | 1 | $155 |
| Cvrx, Inc. | 2 | $149 |
| Penumbra, Inc. | 1 | $146 |
| Edwards Lifesciences | 4 | $140 |
| Bard Peripheral Vascular, Inc. | 2 | $136 |
| Inspiremd Ltd | 2 | $107 |
| Stability Biologics, LLC | 1 | $98 |
| Abbott | 2 | $97 |
| Kerecis Limited | 1 | $80 |
| Stryker | 2 | $69 |
| Lemaitre Vascular, Inc. | 4 | $68 |
| Angiodynamics, Inc. | 3 | $66 |
| Atricure, Inc. | 2 | $66 |
| Imperative Care, Inc | 2 | $45 |
| Medela LLC | 1 | $36 |
| Merck | 1 | $30 |
| Avinger Inc. | 1 | $25 |
| Abiomed | 1 | $24 |
| Biotissue Holdings Inc. | 1 | $24 |
| Smith+Nephew | 1 | $22 |
| Aroa Biosurgery Incorporated | 1 | $17 |
| KCI USA, Inc. | 1 | $17 |
| Convatec Inc. | 1 | $16 |
| Integra Lifesciences Corporation | 1 | $15 |
| Kls-martin L.p. | 1 | $14 |
| Novo Nordisk | 1 | $14 |
| Medistim USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$5,713
- ENROUTE Transcarotid Stent$3,541
- ENHANCE Transcarotid Peripheral Access Kit$1,623
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$1,085
- ENROUTE Transcarotid Stent System$858
- ENROUTE 0.014 Guidewire$858
- ENROUTE .014 Guidewire$765
- TREO ABDOMINAL STENT-GRAFT SYSTEM$545
- AFX$525
- Ovation$525
- GORE TAG Conformable Thoracic Endoprosthesis$286
- GENERAL VASCULAR INTERVENTION$269
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$170
- RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM$166
- Zenith$155
- Penumbra System$146
- ELUVIA$140
- GORE-TEX Vascular Graft$128
- Barostim Neo System$127
- GORE VIABAHN VBX Balloon Expandable Endo$115
How this compares
$13,663 in reported general payments places this provider in the 65th percentile of 385 vascular surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 24 | $20,812 |
| XareltoRivaroxaban | 24 | $15,809 |
| ClopidogrelClopidogrel Bisulfate | 288 | $2,401 |
| Cilostazol | 57 | $899 |
| Prednisone | 18 | $23 |
| Cimetidine | 16 | $21 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $257 | $15,80924 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 385 vascular surgery providers in Florida.
Other vascular surgery in Jacksonville
- Erin MooreJacksonville$488K
- Young ErbenJacksonville$144K
- Timur SaracJacksonville$104K
- Danny VoJacksonville$85K
- Samuel TapperStuart$1.3M
- Mariano ArosemenaBradenton$472K
- Woongchae LeeBoca Raton$414K
- Manuel Perez IzquierdoOrlando$396K
- Murray ShamesTampa$354K
- Joseph RicottaDelray Beach$344K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.